This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Centene (CNC) Boosts Presence in Louisiana With Contract Win
by Zacks Equity Research
Centene's (CNC) latest contract renewal tends to improve health outcomes of Medicaid members of Louisiana.
Community Health (CYH) Ties Up to Offer Enhanced Remote Care
by Zacks Equity Research
Community Health (CYH) teams up with Cadence highlighting its aim of utilizing innovative technology to extend enhanced remote care to patients.
The Zacks Analyst Blog Highlights UnitedHealth Group, Costco Wholesale and Applied Materials
by Zacks Equity Research
UnitedHealth Group, Costco Wholesale and Applied Materials are included in this blog.
Top Research Reports for UnitedHealth, Costco & Applied Materials
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Costco Wholesale Corporation (COST), and Applied Materials, Inc. (AMAT).
Ensign Group (ENSG) Q4 Earnings Match Estimates, Rise Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) Q4 results reflect higher revenues, partly offset by steep expenses.
Tenet Healthcare (THC) Q4 Earnings Beat Estimates, Surge Y/Y
by Zacks Equity Research
Tenet Healthcare (THC) Q4 results reflect lower expenses and operational efficiency along with a strong contribution from its Ambulatory Care segment.
Centene (CNC) Q4 Earnings Beat on Solid Membership Growth
by Zacks Equity Research
Centene's (CNC) fourth-quarter results indicate improved premium and service revenues coupled with sound membership growth. A solid 2022 guidance should impress investors.
Should Invesco Dividend Achievers ETF (PFM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for PFM
Cigna (CI) Q4 Earnings Beat on Robust Cigna Healthcare Unit
by Zacks Equity Research
Cigna's (CI) fourth-quarter results benefit from strong medical customer growth. A solid outlook for 2022 when compared to the 2021 level remains noteworthy.
Encompass Health's (EHC) Q4 Earnings Miss Mark, Increase Y/Y
by Zacks Equity Research
Encompass Health's (EHC) Q4 results reflect escalating costs, partly offset by higher revenues, courtesy of its Inpatient Rehabilitation segment.
Cigna's (CI) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Cigna's (CI) fourth-quarter earnings results likely to reflect higher revenues and solid segmental contributions.
Retail Loss to Affect Humana's (HUM) Q4 Earnings: Here's How
by Zacks Equity Research
Humana's (HUM) fourth-quarter results are likely to reflect growth in medical membership.
UnitedHealth Group (UNH) Boasts Earnings & Price Momentum: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Top Research Reports for Meta Platforms, UnitedHealth & salesforce
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (FB), UnitedHealth Group Incorporated (UNH), and salesforce.com, inc. (CRM).
HCA Healthcare's (HCA) Q4 Earnings Miss Mark, Improve Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) Q4 results reflect higher expenses, partly offset by better revenues owing to improved patient volumes.
UnitedHealth's Solid Q4 Earnings Put These ETFs in Focus
by Sweta Killa
Investors could tap this opportune moment with ETFs having the largest allocation to UnitedHealth.
Company News for Jan 20, 2022
by Zacks Equity Research
Companies In The News Are: JBHT, BAC, UNH, USB.
UnitedHealth (UNH) Q4 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
UnitedHealth's (UNH) Q4 results reflect higher revenues, driven by segmental contributions, partly offset by steep expenses.
UnitedHealth Group (UNH) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 4.19% and 0.95%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
This Abbreviated Trading Week Will Not Be Short Of Earnings Excitement
by Daniel Laboe
I expect this week to set the tone for the remainder of this earnings season
What's in Store for UnitedHealth Group's (UNH) Q4 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) Q4 results are likely to reflect a rise in earnings and revenues on the back of solid segmental contributions.
UnitedHealth Group (UNH) Stock Moves -1.33%: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $467.43, marking a -1.33% move from the previous day.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
by Zacks Equity Research
Sector ETF report for FHLC
UnitedHealth Group (UNH) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth (UNH) Unit Invests to Improve Members' Eye Health
by Zacks Equity Research
UnitedHealth Group's (UNH) business, UnitedHealthcare, offers discount programs and invests in school districts in an effort to improve the eye health of its vision members.